RxNorm 2048568 NDC Crossover

Xeljanz 10 MG Oral Tablet

Related NDC Codes to RxNorm Concept 2048568

The following NDC codes crossover to the RxNorm Concept 2048568. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Labeler Name	Status
0069-0501	Xeljanz XR	Tofacitinib	Tablet, Film Coated, Extended Release	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-0502	Xeljanz XR	Tofacitinib	Tablet, Film Coated, Extended Release	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-1001	Xeljanz	Tofacitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-1002	Xeljanz	Tofacitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-1029	Xeljanz	Tofacitinib	Solution	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
63539-012	Xeljanz	Tofacitinib	Tablet, Film Coated	Oral	U.s. Pharmaceuticals	ACTIVE
63539-016	Xeljanz	Tofacitinib	Tablet, Film Coated	Oral	U.s. Pharmaceuticals	ACTIVE
63539-501	Xeljanz XR	Tofacitinib	Tablet, Extended Release	Oral	U.s. Pharmaceuticals	ACTIVE
63539-502	Xeljanz XR	Tofacitinib	Tablet, Extended Release	Oral	U.s. Pharmaceuticals	ACTIVE